Patents Assigned to Orthomol Pharmazeutische Vertriebs GmbH
  • Patent number: 6835554
    Abstract: A method and corresponding kit for determining the redox status of an organism is provided. The method comprises performing a calorimetric assay of a urine sample by mixing the sample with at least one member of a group of disclosed reagents and an acid and, upon stable color formation, comparing the resulting color to a color scale to indirectly determine the oxidative load, or stress, experienced by that organism. The corresponding kit comprises at least one of the reagents described above, an acid, and a color scale.
    Type: Grant
    Filed: May 29, 2002
    Date of Patent: December 28, 2004
    Assignee: Orthomol Pharmazeutische Vertriebs GmbH
    Inventors: Kristian Glagau, Ralf-Siegbert Hauck
  • Patent number: 5985335
    Abstract: The invention relates to an agent for the prophylaxis and/or therapy of conditions associated with a disorder of bone formation. It contains alkali metal citrates and/or alkali metal lactates and/or alkali metal malates, optionally together with one or more active substances selected from vitamin K, calcium salts and vitamin D. The agent preferably contains potassium citrates and/or sodium citrates or potassium lactates and/or sodium lactates and serves for the prophylaxis and/or therapy of osteoclasis, in particular osteoporosis or osteomalacia.
    Type: Grant
    Filed: November 28, 1997
    Date of Patent: November 16, 1999
    Assignee: Orthomol Pharmazeutische Vertriebs GmbH
    Inventor: Hans Dietl